Yong Gong
Yong Gong has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Rhys Salter
Janssen Research & Development Johnson & Johnson Spring House Pennsylvania USA
5 shared publicationsJie Chen
Drug Metabolism and Pharmacokinetics, Discovery Sciences Janssen Research and Development, Johnson & Johnson Spring House PA USA
2 shared publicationsLu Chen
Janssen Research & Development, Johnson & Johnson, Spring House, Pennsylvania 19477, United States
2 shared publicationsNaidong Weng
Drug Metabolism and Pharmacokinetics, Discovery Sciences Janssen Research and Development, Johnson & Johnson Spring House PA USA
2 shared publicationsWei Zhang
Janssen Research & Development, Johnson & Johnson, Spring House, Pennsylvania 19477, United States
2 shared publications- Barbay
Drug Discovery, Johnson & Johnson PRD, East Coast RED, Spring House, PA 19477-0776, USA
1 shared publication
Latest Publications
- 30 November 2022
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 66 (1) , 4-10
Carbon‐13 labeling of ibrutinib for human microdosing
Ibrutinib is an oral medication for the treatment of B cell malignancies. During its clinical development, a stable isotopologue of ibrutinib was required for the assessment of the drug's absolute oral bioavailability via intravenous microdosing. The following work describes a 10‐step, gram‐scale production of carbon‐13 labeled ibrutinib from [13C6]phenol (13C6, 99%) in 31% overall yield with >99% chemical purity and >99% enantiomeric excess (ee), suitable for intravenous microdosing in humans.
- 30 November 2022
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 66 (1) , 4-10
Carbon‐13 labeling of ibrutinib for human microdosing
Ibrutinib is an oral medication for the treatment of B cell malignancies. During its clinical development, a stable isotopologue of ibrutinib was required for the assessment of the drug's absolute oral bioavailability via intravenous microdosing. The following work describes a 10‐step, gram‐scale production of carbon‐13 labeled ibrutinib from [13C6]phenol (13C6, 99%) in 31% overall yield with >99% chemical purity and >99% enantiomeric excess (ee), suitable for intravenous microdosing in humans.
- 27 June 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (14) , 9330-9342
Nitro-Activated Nucleobase Exchange in the Synthesis of 2′-Fluoro-2′-Deoxyribonucleosides
Functionalized nucleosides bearing pyrimidine or purine bases can be prepared by activation of accessible pyrimidine nucleosides and subsequent transglycosylation. Nitration of lumicitabine, a 2'-fluoro-2'-deoxycytidine class antiviral agent, and its 2'-fluoro-2'-deoxyuridine precursor produce the same 5-nitro-2'-fluoro-2'-deoxyuridine. Under Vorbrüggen conditions, 5-nitrouracil serves as the leaving nucleobase and enables exchange with pyrimidine and purine nucleobases to anomeric 2'-fluoro-2'-deoxyribonucleosides in favor of β-anomers generally. The strategy is also applied in the isotopic labeling of 2'-fluoro-2'-deoxyuridines.
- 27 June 2022
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 87 (14) , 9330-9342
Nitro-Activated Nucleobase Exchange in the Synthesis of 2′-Fluoro-2′-Deoxyribonucleosides
Functionalized nucleosides bearing pyrimidine or purine bases can be prepared by activation of accessible pyrimidine nucleosides and subsequent transglycosylation. Nitration of lumicitabine, a 2'-fluoro-2'-deoxycytidine class antiviral agent, and its 2'-fluoro-2'-deoxyuridine precursor produce the same 5-nitro-2'-fluoro-2'-deoxyuridine. Under Vorbrüggen conditions, 5-nitrouracil serves as the leaving nucleobase and enables exchange with pyrimidine and purine nucleobases to anomeric 2'-fluoro-2'-deoxyribonucleosides in favor of β-anomers generally. The strategy is also applied in the isotopic labeling of 2'-fluoro-2'-deoxyuridines.
- 13 September 2021
- Published by Wiley in Biomedical Chromatography
- Vol. 36 (1) , e5242
Bifunctionalized isotopologs as calibrants for standard‐free quantitation of drug metabolites in plasma by liquid chromatography coupled with radiometry and mass spectrometry
The reported method involves a novel workflow that eliminates the need for authentic reference standards for the quantitation of drug metabolites in biological samples using a single multi‐isotopically labeled compound bearing both radio and stable isotopes. The resulting radio and stable bifunctionalized isotopolog (RADSTIL) of the parent drug is employed as a substrate for in vitro biotransformation to targeted RADSTILs of metabolites as calibrants. Inclusion of a radio label enables both radiometric and mass spectrometric detection. The addition of stable labels ensures the subsequent isotopic interference‐free quantitation of unlabeled metabolites in preclinical and clinical samples. This affords a more accurate quantitation workflow compared with the current semi‐quantitation method, which utilizes isotopic interfering radio isotopologs of metabolites alone as calibrants. The proof‐of‐concept is illustrated with (14C,13C2)‐acetaminophen where in vitro biotransformation produced (14C,13C2)‐sulfate and (14C,13C2)‐glucuronide calibrants. Absolute quantitation of the acetaminophen metabolites was then achieved by liquid chromatography coupled with radiometry and mass spectrometry. Quantitative data obtained by this method fell within 82–86% of the values from conventional LC–MS/MS method.
- 13 September 2021
- Published by Wiley in Biomedical Chromatography
- Vol. 36 (1) , e5242
Bifunctionalized isotopologs as calibrants for standard‐free quantitation of drug metabolites in plasma by liquid chromatography coupled with radiometry and mass spectrometry
The reported method involves a novel workflow that eliminates the need for authentic reference standards for the quantitation of drug metabolites in biological samples using a single multi‐isotopically labeled compound bearing both radio and stable isotopes. The resulting radio and stable bifunctionalized isotopolog (RADSTIL) of the parent drug is employed as a substrate for in vitro biotransformation to targeted RADSTILs of metabolites as calibrants. Inclusion of a radio label enables both radiometric and mass spectrometric detection. The addition of stable labels ensures the subsequent isotopic interference‐free quantitation of unlabeled metabolites in preclinical and clinical samples. This affords a more accurate quantitation workflow compared with the current semi‐quantitation method, which utilizes isotopic interfering radio isotopologs of metabolites alone as calibrants. The proof‐of‐concept is illustrated with (14C,13C2)‐acetaminophen where in vitro biotransformation produced (14C,13C2)‐sulfate and (14C,13C2)‐glucuronide calibrants. Absolute quantitation of the acetaminophen metabolites was then achieved by liquid chromatography coupled with radiometry and mass spectrometry. Quantitative data obtained by this method fell within 82–86% of the values from conventional LC–MS/MS method.
- 6 July 2020
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 22 (14) , 5577-5581
Transglycosylation in the Modification and Isotope Labeling of Pyrimidine Nucleosides
Transglycosylation of pyrimidine nucleosides is demonstrated in a one-pot synthesis of uridine derivatives under microwave irradiation. Inductive activation of 2′,3′,5′-tri-O-acetyl uridine with a 5-nitro group produces a more-reactive glycosyl donor. Under optimized Vorbrüggen conditions, the 5-nitrouridine facilitates a reversible nucleobase exchange with a series of 5-substituted uracils. The protocol is also exemplified in a gram-scale reaction under thermal heating. The strategy provides easy access to isotopically labeled uridine.
- 6 July 2020
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 22 (14) , 5577-5581
Transglycosylation in the Modification and Isotope Labeling of Pyrimidine Nucleosides
Transglycosylation of pyrimidine nucleosides is demonstrated in a one-pot synthesis of uridine derivatives under microwave irradiation. Inductive activation of 2′,3′,5′-tri-O-acetyl uridine with a 5-nitro group produces a more-reactive glycosyl donor. Under optimized Vorbrüggen conditions, the 5-nitrouridine facilitates a reversible nucleobase exchange with a series of 5-substituted uracils. The protocol is also exemplified in a gram-scale reaction under thermal heating. The strategy provides easy access to isotopically labeled uridine.
- 25 July 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 89 (16) , 8399-8404
Standard-Free Bioanalytical Approach for Absolute Quantitation of Drug Metabolites Utilizing Biosynthesis of Reciprocal Radio and Stable Isotopologues and Its Application
The following work describes a combined enzymatic and bioanalytical method that permits absolute quantitation of metabolites in biological samples without the requirement for reference metabolite standards. This technique was exemplified using a radio (14C) isotopologue and a stable (13C6) isotopologue of acetaminophen as substrates for in vitro biosynthesis of the corresponding radio and stable isotope labeled metabolites, namely, 14C- and 13C6-glucuronides and sulfates. By supplanting the use of authentic metabolite standards, traditionally used to calibrate 13C6-metabolites via liquid chromatography-tandem mass spectrometry (LC-MS/MS), 13C6-metabolites were radiocalibrated by their 14C-isotopologues via liquid chromatography coupled with radioactivity detection and mass spectrometry (LC-RAD/MS). The radiocalibrated 13C6-isotopologues were in turn used to quantitate acetaminophen and its corresponding metabolites in rat plasma samples by LC-MS/MS. Variation between this and a conventional LC-MS/MS method using authentic standards for calibration was within ±17%, permitting its use in preclinical and clinical applications. Since authentic metabolite standards are not required under the concept of radio and stable isotopologues using adapted LC-RAD/MS protocols, significantly fewer resources are required to support accurate metabolite quantitation which in turn enables efficient analysis of simple and complex metabolite profiles.
- 25 July 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 89 (16) , 8399-8404
Standard-Free Bioanalytical Approach for Absolute Quantitation of Drug Metabolites Utilizing Biosynthesis of Reciprocal Radio and Stable Isotopologues and Its Application
The following work describes a combined enzymatic and bioanalytical method that permits absolute quantitation of metabolites in biological samples without the requirement for reference metabolite standards. This technique was exemplified using a radio (14C) isotopologue and a stable (13C6) isotopologue of acetaminophen as substrates for in vitro biosynthesis of the corresponding radio and stable isotope labeled metabolites, namely, 14C- and 13C6-glucuronides and sulfates. By supplanting the use of authentic metabolite standards, traditionally used to calibrate 13C6-metabolites via liquid chromatography-tandem mass spectrometry (LC-MS/MS), 13C6-metabolites were radiocalibrated by their 14C-isotopologues via liquid chromatography coupled with radioactivity detection and mass spectrometry (LC-RAD/MS). The radiocalibrated 13C6-isotopologues were in turn used to quantitate acetaminophen and its corresponding metabolites in rat plasma samples by LC-MS/MS. Variation between this and a conventional LC-MS/MS method using authentic standards for calibration was within ±17%, permitting its use in preclinical and clinical applications. Since authentic metabolite standards are not required under the concept of radio and stable isotopologues using adapted LC-RAD/MS protocols, significantly fewer resources are required to support accurate metabolite quantitation which in turn enables efficient analysis of simple and complex metabolite profiles.
- 19 July 2011
- Published by Springer Nature in Environmental Chemistry Letters
- Vol. 9 (4) , 547-552
Phytotoxicity and uptake of chlorpyrifos in cabbage
- 19 July 2011
- Published by Springer Nature in Environmental Chemistry Letters
- Vol. 9 (4) , 547-552
Phytotoxicity and uptake of chlorpyrifos in cabbage
- 1 April 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (8) , 2544-2548
Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists
- 1 April 2008
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (8) , 2544-2548
Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists